8,193 Shares in Astera Labs, Inc. $ALAB Bought by Oppenheimer Asset Management Inc.

Oppenheimer Asset Management Inc. acquired a new stake in Astera Labs, Inc. (NASDAQ:ALAB) during the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm acquired 8,193 shares of the company’s stock, valued at approximately $3,957,000.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Reflection Asset Management bought a new position in shares of Astera Labs in the 4th quarter valued at $25,000. Smartleaf Asset Management LLC increased its holdings in Astera Labs by 422.2% in the 4th quarter. Smartleaf Asset Management LLC now owns 188 shares of the company’s stock worth $32,000 after purchasing an additional 152 shares in the last quarter. Towarzystwo Funduszy Inwestycyjnych PZU SA bought a new position in Astera Labs in the fourth quarter valued at about $33,000. Whipplewood Advisors LLC boosted its stake in shares of Astera Labs by 15,950.0% during the first quarter. Whipplewood Advisors LLC now owns 321 shares of the company’s stock valued at $35,000 after purchasing an additional 319 shares in the last quarter. Finally, Assetmark Inc. grew its holdings in shares of Astera Labs by 78.9% during the fourth quarter. Assetmark Inc. now owns 229 shares of the company’s stock worth $38,000 after purchasing an additional 101 shares during the last quarter. Institutional investors own 60.47% of the company’s stock.

Insiders Place Their Bets

In other news, Director Manuel Alba sold 8,491 shares of Astera Labs stock in a transaction dated Wednesday, July 1st. The stock was sold at an average price of $458.38, for a total value of $3,892,104.58. Following the completion of the transaction, the director directly owned 286,863 shares of the company’s stock, valued at approximately $131,492,261.94. This trade represents a 2.87% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Bethany Mayer sold 686 shares of Astera Labs stock in a transaction dated Wednesday, June 24th. The stock was sold at an average price of $395.04, for a total value of $270,997.44. Following the completion of the transaction, the director directly owned 5,550 shares of the company’s stock, valued at approximately $2,192,472. This trade represents a 11.00% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last 90 days, insiders have sold 1,256,894 shares of company stock valued at $362,763,135. 10.40% of the stock is currently owned by insiders.

Astera Labs Stock Performance

NASDAQ:ALAB opened at $321.61 on Friday. The firm’s fifty day moving average is $358.00 and its 200-day moving average is $240.20. Astera Labs, Inc. has a 52 week low of $97.89 and a 52 week high of $499.48. The firm has a market cap of $55.80 billion, a P/E ratio of 159.21 and a beta of 3.84.

Astera Labs (NASDAQ:ALAB) last posted its quarterly earnings data on Tuesday, August 4th. The company reported $0.80 earnings per share for the quarter, topping the consensus estimate of $0.69 by $0.11. The company had revenue of $392.40 million during the quarter, compared to analysts’ expectations of $360.85 million. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. Astera Labs’s revenue for the quarter was up 104.5% compared to the same quarter last year. During the same period in the prior year, the company posted $0.44 earnings per share. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. As a group, sell-side analysts anticipate that Astera Labs, Inc. will post 2.7 earnings per share for the current year.

Wall Street Analyst Weigh In

ALAB has been the subject of a number of research reports. Bank of America raised their price objective on shares of Astera Labs from $240.00 to $450.00 and gave the company a “neutral” rating in a report on Tuesday, June 23rd. Northland Securities downgraded shares of Astera Labs from an “outperform” rating to a “market perform” rating in a research note on Tuesday, May 26th. TD Cowen cut their price target on shares of Astera Labs from $425.00 to $375.00 and set a “hold” rating on the stock in a report on Wednesday, August 5th. Barclays boosted their price objective on shares of Astera Labs from $200.00 to $325.00 and gave the stock an “equal weight” rating in a research note on Monday, July 20th. Finally, Royal Bank Of Canada increased their price objective on Astera Labs from $425.00 to $500.00 and gave the company an “outperform” rating in a report on Wednesday, August 5th. One analyst has rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and nine have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $325.25.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.